TY - JOUR
T1 - Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival
AU - Fukumoto, Akiko
AU - Maruyama, Kazuichi
AU - Walsh, Tony
AU - Kajiya, Kentaro
AU - Hamuro, Junji
AU - D'Amore, Patricia A.
AU - Kinoshita, Shigeru
PY - 2010/5
Y1 - 2010/5
N2 - Purpose. Compounds regulating intracellular thiol redox status, such as N,N-diacetyl-L-cystine dimethylester (NM2), were shown to prolong corneal graft survival in a penetrating keratoplasty (PKP) model. However, the effect of NM2 on hemangiogenesis and lymphangiogenesis has not been investigated. The effect of manipulating ambient thiol redox status on riskier (higher rejection rate) transplantation models, such as limbal graft survival and hemangiogenesis and lymphangiogenesis in a corneal suture model, were investigated. Methods. C57BL/10 mice that received BALB/c corneas were treated by subconjunctival injection of NM2, and limbal graft survival was assessed. Sutured C57BL/6 received daily intraperitoneal injections of NM2, glutathione diethylester (GSHOEt), or PBS. Lymphatic endothelial cell (LEC) and peritoneal mps were treated with NM2 or GSHOEt, and then VEGFR3, neuropilin-2, podoplanin, and LYVE-1 expression were analyzed. Supernatants were collected for analysis of TNF-α and VEGF-A levels by ELISA. Results. Significantly less cellular infiltration was detected in mice with corneal limbal transplant-treated NM2-treated mice. Hemangiogenesis and lymphangiogenesis were suppressed in the NM2-treated mice. NM2 treatment of mps led to reduced levels of VEGFR3, neuropilin-2, podoplanin, and LYVE-1 expression compared with PBS- or GSHOEt- treated mps, lower levels of TNF-α, and increased secretion of VEGF. Moreover, NM2-treated LECs had reduced levels of LYVE-1 and Prox-1. Conclusions. Reduction of ambient redox status reduced inflammatory cell infiltrates. Consequently, reduced inflammatory response might have contributed to both the observed prolonged corneal limbal graft survival and the attenuated hemangiogenesis and lymphangiogenesis in cornea.
AB - Purpose. Compounds regulating intracellular thiol redox status, such as N,N-diacetyl-L-cystine dimethylester (NM2), were shown to prolong corneal graft survival in a penetrating keratoplasty (PKP) model. However, the effect of NM2 on hemangiogenesis and lymphangiogenesis has not been investigated. The effect of manipulating ambient thiol redox status on riskier (higher rejection rate) transplantation models, such as limbal graft survival and hemangiogenesis and lymphangiogenesis in a corneal suture model, were investigated. Methods. C57BL/10 mice that received BALB/c corneas were treated by subconjunctival injection of NM2, and limbal graft survival was assessed. Sutured C57BL/6 received daily intraperitoneal injections of NM2, glutathione diethylester (GSHOEt), or PBS. Lymphatic endothelial cell (LEC) and peritoneal mps were treated with NM2 or GSHOEt, and then VEGFR3, neuropilin-2, podoplanin, and LYVE-1 expression were analyzed. Supernatants were collected for analysis of TNF-α and VEGF-A levels by ELISA. Results. Significantly less cellular infiltration was detected in mice with corneal limbal transplant-treated NM2-treated mice. Hemangiogenesis and lymphangiogenesis were suppressed in the NM2-treated mice. NM2 treatment of mps led to reduced levels of VEGFR3, neuropilin-2, podoplanin, and LYVE-1 expression compared with PBS- or GSHOEt- treated mps, lower levels of TNF-α, and increased secretion of VEGF. Moreover, NM2-treated LECs had reduced levels of LYVE-1 and Prox-1. Conclusions. Reduction of ambient redox status reduced inflammatory cell infiltrates. Consequently, reduced inflammatory response might have contributed to both the observed prolonged corneal limbal graft survival and the attenuated hemangiogenesis and lymphangiogenesis in cornea.
UR - http://www.scopus.com/inward/record.url?scp=77952500458&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952500458&partnerID=8YFLogxK
U2 - 10.1167/iovs.09-4618
DO - 10.1167/iovs.09-4618
M3 - Article
C2 - 20042658
AN - SCOPUS:77952500458
SN - 0146-0404
VL - 51
SP - 2450
EP - 2458
JO - Investigative Ophthalmology
JF - Investigative Ophthalmology
IS - 5
ER -